Expect a Limited Role for Ceftobiprole
July 2025
You’ll get questions about ceftobiprole medocaril (Zevtera)...a new IV antibiotic that targets methicillin-resistant Staph.
It’s a fifth-generation cephalosporin similar to ceftaroline that’s been used in Europe for over a decade...and is used for infections from S. aureus (including MRSA) and some gram-negatives (Klebsiella, etc).
For example, it’s FDA-approved for S. aureus bacteremia, acute bacterial skin infections, and community-acquired pneumonia (CAP).
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote